Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma†
Akira Kawai(NTT (Japan)), Kazuo Isu(Hokkaido University Hospital), Shun Asami(Eisai (Japan)), Kenichi Saito(Zenyaku Kogyo (Japan)), Akihiko Matsumine(University of Fukui), Yoichi Naito(National Cancer Center Hospital East), Yasuo Yazawa, Hideshi Sugiura, Toshifumi Ozaki(Okayama University), Nobuhito Araki(Ashiya University), Hideo Morioka
Cited by 67
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2021|453
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343